Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.
Mohamed Osama MohamedNick CurzenMark de BelderAndrew T GoodwinJames C SprattLognathen BalacumaraswamiJohn DeanfieldGlen P MartinMuhammad RashidAhmad ShoaibChris P GaleTim KinnairdMamas A MamasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
LM revascularisation activity has significantly declined during the COVID period, with a shift towards PCI as the preferred strategy. Postprocedural mortality within each revascularisation group was similar in the pre-COVID and COVID periods, reflecting maintenance in quality of outcomes during the pandemic. Future measures are required to safely restore LM revascularisation activity to pre-COVID levels.
Keyphrases
- coronavirus disease
- sars cov
- coronary artery disease
- respiratory syndrome coronavirus
- coronary artery
- acute coronary syndrome
- percutaneous coronary intervention
- heart failure
- risk factors
- type diabetes
- acute myocardial infarction
- adipose tissue
- cardiovascular events
- quality improvement
- metabolic syndrome
- left ventricular
- st segment elevation myocardial infarction
- current status